The therapeutic potential of long noncoding RNAs (lncRNAs) in acute myeloid leukemia (AML) remains unclear. In this study, we identified a novel lncRNA and indicated that it may be associated with the treatment of AML and could be a new biomarker and therapeutic target for AML.
Clinical data and genetic features of six Chinese families including ADPKD patients were analyzed via Next generation sequencing (NGS), Sanger sequencing, and multiplex ligation-dependent probe amplification.
Conventional chemotherapy can kill the cancer cells and, whereas, would exacerbate the metastasis and drug resistance. Here, a new combinatorial treatment strategywas probed via dosing dual nanomedicines, marimastat‐loaded thermosensitive liposomes (MATT‐LTSLs) and paclitaxel nanocrystals (PTX‐Ns).